Oncology, Etc. - In Conversation with Dr. David Steensma (Part 1)

ASCO Education

Contenu fourni par ASCO Education and American Society of Clinical Oncology (ASCO). Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par ASCO Education and American Society of Clinical Oncology (ASCO) ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

2y ago 23:01

MP3•Maison d'episode

In this Oncology, Etc. episode, hosts Patrick Loehrer and David Johnson interview hematologist-oncologist and scientist Dr. David Steensma, who currently serves as Head of Global Hematology at Novartis. In Part One of the episode, Dr. Steensma shares about his career journey from astronomy to medicine, and from academia to industry. We’ll also learn about the discovery and significance of a new pre-malignant condition - Clonal Hematopoiesis of Indeterminate Potential (CHIP).

If you liked this episode, please subscribe. Learn more at https://education.asco.org, or email us at

198 episodes

#Fitness #Oncology #Science #Medicine #Cancer #Americansocietyofclinicaloncology #American Society of Clinical Oncology (ASCO #ASCO Education #ASCO #Health and Well-Being